The store will not work correctly when cookies are disabled.
(E)-3-((1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)thiochroman-4-one
ID: ALA4638373
PubChem CID: 156012713
Max Phase: Preclinical
Molecular Formula: C17H12N2OS
Molecular Weight: 292.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1/C(=C\c2c[nH]c3ncccc23)CSc2ccccc21
Standard InChI: InChI=1S/C17H12N2OS/c20-16-12(10-21-15-6-2-1-4-14(15)16)8-11-9-19-17-13(11)5-3-7-18-17/h1-9H,10H2,(H,18,19)/b12-8-
Standard InChI Key: XJDMDNVSHBCBLV-WQLSENKSSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
12.3184 -13.2195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3172 -14.0390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0253 -14.4480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0235 -12.8106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7321 -13.2159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7323 -14.0391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5153 -14.2932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9990 -13.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5149 -12.9613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7672 -12.1841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2202 -11.5769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4765 -10.8001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9334 -10.1943 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.4245 -11.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8785 -11.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1345 -10.3639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5926 -9.7572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7947 -9.9234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5415 -10.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0850 -11.3050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1720 -12.5266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
11 14 1 0
12 13 1 0
13 16 1 0
15 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
14 21 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.36 | Molecular Weight (Monoisotopic): 292.0670 | AlogP: 3.93 | #Rotatable Bonds: 1 |
Polar Surface Area: 45.75 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.28 | CX LogP: 3.30 | CX LogD: 3.30 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.69 | Np Likeness Score: -0.81 |
References
1. Qhobosheane MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Petzer JP, Beteck RM.. (2020) Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors., 28 (11): [PMID:32284225] [10.1016/j.bmc.2020.115468] |